Full Text View
Tabular View
No Study Results Posted
Related Studies
Forearm Vascular Relaxation
This study has been completed.
First Received: September 12, 2005   Last Updated: August 28, 2008   History of Changes
Sponsor: National Institute on Aging (NIA)
Information provided by: National Institute on Aging (NIA)
ClinicalTrials.gov Identifier: NCT00182923
  Purpose

The purpose of this study is to learn the effect of inherited differences on forearm blood flow responses to hormones and drugs


Condition
Healthy

Study Type: Observational
Study Design: Prospective
Official Title: Determinants of Forearm Vascular Relaxation: Role of Genetic Polymorphisms

Further study details as provided by National Institute on Aging (NIA):

Estimated Enrollment: 400
Study Start Date: May 2003
Study Completion Date: December 2006
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Differences in at least 4 genes are believed to have an important effect on responses to hormones and drugs. For this study, healthy volunteers of normal body weight will be screened to find xxx individuals with the genes of interest. Very small doses of hormones and drugs will be given so that changes in forearm blood flow can be measured, while not causing effects throughout the body. A brachial artery line and venous line will be placed in the study arm so that blood samples may be withdrawn to compare amounts given into the artery and coming out of the vein after circulating through the arm. Forearm blood flow is determined by the rate of swelling of the arm after a blood pressure cuff is inflated (above venous and below arterial blood pressure). The hormones and drugs being studied include angiotensin I, angiotensin II, acetylcholine, sodium nitroprusside, enalaprilat, L-arginine, phenylephrine, endothelin-1, verapamil, and isoproterenol. This procedure will last 4-6 hours. The process will be repeated with the same participant over 2 weeks later.

  Eligibility

Ages Eligible for Study:   21 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Normal physical status without any medical interventions or agents which would alter the defined status of normal

Exclusion Criteria:

  • Age less than 21 or greater than 45
  • Unable to give informed consent
  • BMI (Body Mass Index) less than 18 or greater than 25
  • Clinically significant abnormal laboratory values
  • Abnormal physical exam
  • Abnormal EKG
  • Pregnancy
  • Smoking or drug usage (illicit or otherwise)
  • Post-menopause
  • Participation in another clinical trial in the past month
  • Chronic Illness
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00182923

Locations
United States, Maryland
National Institute on Aging (NIA), Harbor Hospital
Baltimore, Maryland, United States, 21225
Sponsors and Collaborators
Investigators
Principal Investigator: Darrell R. Abernethy, MD, PhD National Institute on Aging, Laboratory of Clinical Investigation
  More Information

Additional Information:
Publications:
Study ID Numbers: AG0038
Study First Received: September 12, 2005
Last Updated: August 28, 2008
ClinicalTrials.gov Identifier: NCT00182923     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institute on Aging (NIA):
Blood pressure
genetics

ClinicalTrials.gov processed this record on November 27, 2009